| MicroRNAs: biomarkers, diagnostics, and therapeutics W Huang Bioinformatics in MicroRNA research, 57-67, 2017 | 267 | 2017 |
| Evidence of significant contribution from CYP3A5 to hepatic drug metabolism W Huang, YS Lin, DJ McConn II, JC Calamia, RA Totah, N Isoherranen, ... Drug Metabolism and Disposition 32 (12), 1434-1445, 2004 | 252 | 2004 |
| Mechanistic approaches to predicting oral drug absorption W Huang, SL Lee, LX Yu The AAPS journal 11, 217-224, 2009 | 213 | 2009 |
| Structure-aware interactive graph neural networks for the prediction of protein-ligand binding affinity S Li, J Zhou, T Xu, L Huang, F Wang, H Xiong, W Huang, D Dou, H Xiong Proceedings of the 27th ACM SIGKDD conference on knowledge discovery & data …, 2021 | 189 | 2021 |
| In vitro metabolism of cyclosporine A by human kidney CYP3A5 Y Dai, K Iwanaga, YS Lin, MF Hebert, CL Davis, W Huang, ED Kharasch, ... Biochemical pharmacology 68 (9), 1889-1902, 2004 | 176 | 2004 |
| Determination of free and total cortisol in plasma and urine by liquid chromatography-tandem mass spectrometry W Huang, TF Kalhorn, M Baillie, DD Shen, KE Thummel Therapeutic drug monitoring 29 (2), 215-224, 2007 | 49 | 2007 |
| OmniSearch: a semantic search system based on the Ontology for MIcroRNA Target (OMIT) for microRNA-target gene interaction data J Huang, F Gutierrez, HJ Strachan, D Dou, W Huang, B Smith, JA Blake, ... Journal of biomedical semantics 7, 1-17, 2016 | 39 | 2016 |
| The Non-Coding RNA Ontology (NCRO): a comprehensive resource for the unification of non-coding RNA biology J Huang, K Eilbeck, B Smith, JA Blake, D Dou, W Huang, DA Natale, ... Journal of biomedical semantics 7, 1-12, 2016 | 14 | 2016 |
| The development of non-coding RNA ontology J Huang, K Eilbeck, B Smith, JA Blake, D Dou, W Huang, DA Natale, ... International journal of data mining and bioinformatics 15 (3), 214-232, 2016 | 13 | 2016 |
| Giant: Protein-ligand binding affinity prediction via geometry-aware interactive graph neural network S Li, J Zhou, T Xu, L Huang, F Wang, H Xiong, W Huang, D Dou, H Xiong IEEE Transactions on Knowledge and Data Engineering, 2023 | 10 | 2023 |
| II, Calamia JC, Totah RA, Isoherranen N, Glodowski M, Thummel KE W Huang, YS Lin, DJ McConn Evidence of significant contribution from CYP3A5 to hepatic drug metabolism …, 2004 | 4 | 2004 |
| CYP3A5 catalyzed cortisol 6 beta-hydroxylation in liver and kidney WL Huang, TF Kalhorn, M Baillie, KE Thummel DRUG METABOLISM REVIEWS 36, 77-77, 2004 | 1 | 2004 |
| Comparative drug metabolism by CYP3A4 and CYP3A5 WL Huang, YS Lin, Y Dai, RA Totah, JC Calamia, KE Thummel DRUG METABOLISM REVIEWS 35, 187-187, 2003 | 1 | 2003 |
| Information processing method and device LI Shuangli, Z Jingbo, T Xu, L Huang, F Wang, H Xiong, W Huang, ... US Patent App. 17/565,910, 2022 | | 2022 |
| Method of training prediction model for determining molecular binding force LI Shuangli, Z Jingbo, T Xu, L Huang, F Wang, H Xiong, W Huang, ... US Patent App. 17/570,416, 2022 | | 2022 |
| OmniSearch: a semantic search system based on the Ontology for MIcroRNA Target (OMIT) for microRNA-target gene interaction data Z Liu, J Huang, HJ Strachan, D Dou, W Huang, B Smith, JA Blake, ... | | 2016 |
| The inhibition effects of acute and chronic ritonavir treatment on hepatic and renal cortisol clearance in healthy volunteers W Huang, KE Thummel, ED Kharasch DRUG METABOLISM REVIEWS 38, 171-172, 2006 | | 2006 |
| Impact of CYP3A5 and P-glycoprotein on Hepatic and Renal Drug Clearance W Huang ProQuest, 2006 | | 2006 |
| In vitro metabolism of cyclosporine A by human kidney microsomal CYP3A5 Y Dai, K Iwanaga, YS Lin, W Huang, KE Thummel DRUG METABOLISM REVIEWS 35, 188-188, 2003 | | 2003 |
